Case History of a Novel Treatment Approach for Congenital Cardiomyopathy due to Carnitine Transporter Deficiency _Crimson Publishers


     

This is a case study of a novel experimental therapy approach in a rare treatment non-responsive potentially fatal Carnitine Transporter Deficiency Congenital Cardiomyopathy. The child's LVEF was down to about 24% at presentation. As a last resort, we tried out a new multidisciplinary therapy approach. It restored his treatment response and raised his LVEF to a persistent level of 80 to 84% as followed up for last two years. Three of his similarly affected siblings: two brothers and one sister, had earlier succumbed in spite of optimum Levo-Carnitine supplement (the only approved treatment) as provided by one of the most prestigious Medical Institutes of his country

For more open access journals in Crimson Publishers please click on link: https://crimsonpublishers.com/
For more articles in open access Disabilities journals please click on link: https://crimsonpublishers.com/didd/

Comments

Popular posts from this blog

The Ideological Basis of Stupidity: Journal of Intellectual and Developmental Disability: Crimson Publishers